Pasar al contenido principal

LAS CELULAS PROGENITORAS HEPATICAS COMO DIANA DE LA VIA HGF/MET, SOLA O CONJUNTAMENTE CON LA VIA DE TGF-B, EN EL CRUCE ENTRE LA REGENERACION HEPATICA Y LA PROGRESION DEL DAÑO

PID2021-124830OB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2021
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD COMPLUTENSE DE MADRID

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Uncovering a Novel Functional Interaction Between Adult Hepatic Progenitor Cells, Inflammation and EGFR Signaling During Bile Acids-Induced Injury

  • García-Sáez, Juan
  • Figueroa-Fuentes, María
  • González-Corralejo, Carlos
  • Roncero, Cesáreo
  • Lazcanoiturburu, Nerea
  • Gutiérrez-Uzquiza, Álvaro
  • Vaquero, Javier
  • González-Sánchez, Ester
  • Bhutia, Kunzangla
  • Calero-Pérez, Silvia
  • Maina, Flavio
  • Traba, Javier
  • Valverde, Ángela M.
  • Fabregat, Isabel
  • Herrera, Blanca
  • Sánchez, Aránzazu
Chronic cholestatic damage is associated to both accumulation of cytotoxic levels of bile acids and expansion of adult hepatic progenitor cells (HPC) as part of the ductular reaction contributing to the regenerative response. Here, we report a bile acid-specific cytotoxic response in mouse HPC, which is partially impaired by EGF signaling. Additionally, we show that EGF synergizes with bile acids to trigger inflammatory signaling and NLRP3 inflammasome activation in HPC. Aiming at understanding the impact of this HPC specific response on the liver microenvironment we run a proteomic analysis of HPC secretome. Data show an enrichment in immune and TGF-β regulators, ECM components and remodeling proteins in HPC secretome. Consistently, HPC-derived conditioned medium promotes hepatic stellate cell (HSC) activation and macrophage M1-like polarization. Strikingly, EGF and bile acids co-treatment leads to profound changes in the secretome composition, illustrated by an abolishment of HSC activating effect and by promoting macrophage M2-like polarization. Collectively, we provide new specific mechanisms behind HPC regulatory action during cholestatic liver injury, with an active role in cellular interactome and inflammatory response regulation. Moreover, findings prove a key contribution for EGFR signaling jointly with bile acids in HPC-mediated actions., This work was supported by Ministry of Science and Innovation, Spanish Agency of Research cofounded by FEDER (grants RTI2018-099098-B-100 to AS/BH; and grants PID2021-124830OB-100 and PID2021-122766OB-100 funded by MCIN/AEI/10.13039/501100011033 / FEDER, UE, to AS/BH and AMV, respectively) and by Fundación Ramon Areces, grant #CIVP20A6593, to IF. NL was supported by RTI2018-099098-B-100. JGS and MF were supported by UCM Santander predoctoral contract and Investigo Program Grant, respectively.The CIBEREHD is funded by the Instituto de Salud Carlos III, Spain. We thank CERCA programme/Generalitat de Catalunya for institutional support.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Deletion of C3G in hepatocytes impairs full liver maturation and alters glucose homeostasis

  • Palao, Nerea
  • Mancebo, Jaime
  • Baquero, Cristina
  • Iniesta-González, Minerva
  • Cueto-Remacha, Mateo
  • Rodrigo-Faus, María
  • Gutiérrez-Uzquiza, Álvaro
  • Bragado, Paloma
  • Cuesta, Ángel M.
  • Sánchez, Aranzazu
  • Guerrero Arroyo, María del Carmen
  • Porras, Almudena
C3G (RapGEF1) regulates the biology of liver hepatic progenitor cells and hepatocarcinoma cells, but its role in hepatocytes remained unknown. Therefore, we generated a mouse model lacking C3G in hepatocytes (C3GKOAlb), which showed liver damage as evidenced by increased fibrosis, liver macrophages and serum transaminases activity. Furthermore, impaired liver maturation was observed in C3GKOAlb mice demonstrated by the low expression of hepatocyte specific proteins (i.e. HNF4α), but higher levels of Alpha-fetoprotein, and stemness markers (i.e. CD133). Glucose homeostasis was also altered in C3GKOAlb mice, as well as insulin and glucagon effects on hepatocytes, which resulted in reduced serum glucose levels and an enhanced response to glucagon. In addition, the expression of several glycolytic and gluconeogenic enzymes, as well as the levels of the active form of Glycogen phosphorylase (PYGL), were upregulated in livers from C3GKOAlb mice, being remarkable the increased Pyruvate kinase isoform 2 (PKM2) levels accompanied by higher serum lactate concentrations. An increased expression of the ketogenic enzyme 3-hydroxy 3-methylglutaryl-CoA (HMG) synthase (Hmgcs2) was also found in these livers in parallel to elevated blood levels of beta-hydroxy-butyrate. Moreover, the fasting response was enhanced in C3GKOAlb mice as compared to wt animals. Hence, livers lacking C3G in hepatocytes showed a higher expression of gluconeogenic, lipogenic and ketogenic enzymes than livers from wt mice and enhanced ketogenesis. Mechanistically, data support a PTBP1-mediated upregulation of PKM2 expression in hepatocytes lacking C3G, which leads to enhanced glycolysis. Other metabolic alterations are likely due to the defective insulin signaling and the enhanced glucagon signaling through a cAMP-PKA-dependent mechanism. In summary, we have identified a novel role for C3G in the liver as a key mediator of hepatocyte differentiation and metabolic functions of hepatocytes. Hence, its absence leads to an immature phenotype and an altered response to insulin and glucagon, favoring glucagon actions., This work was supported by grants from the Spanish Ministry of Science, Innovation and Universities [PID2022-137717OB-C21 to AP/AMC; PID2019-104143RB-C22 to AP; PID2022-137717OB-C22 to CG; PID2019-104143RB-C21 to CG; PID2021-124830OB-I00 to AS; PID2019-104991RB-I00 and PID2022-136959OB-I00 to PB, PID2020-117650RA-I00 and CNS2023-144109 to AG-U, PID2021-124830OB-I00 to AS and funded by MICIU/AEI/10.13039/501100011033]. All funding was cosponsored by the European “ERDF A way of making Europe”. NP was a recipient of an FPU fellowship from the Spanish Ministry of Education. CB was supported by the PID2019-104143RB-C22 grant. MI-G is supported by a predoctoral contract from Comunidad de Madrid. MC-R is a recipient of a predoctoral contract from UCM and JM by the PID2022-137717OB-C21 grant., Peer reviewed
Docta Complutense
Publicación Artículo científico (JournalArticle)

New and Old Key Players in Liver Cancer

  • Cuesta Martínez, Ángel
  • Palao, Nerea
  • Bragado Domingo, Paloma
  • Gutiérrez Uzquiza, Álvaro
  • Herrera González, Blanca María
  • Sánchez Muñoz, Aranzazu
  • Porras Gallo, María Almudena
Liver cancer represents a major health problem worldwide with growing incidence and high mortality, hepatocellular carcinoma (HCC) being the most frequent. Hepatocytes are likely the cellular origin of most HCCs through the accumulation of genetic alterations, although hepatic progenitor cells (HPCs) might also be candidates in specific cases, as discussed here. HCC usually develops in a context of chronic inflammation, fibrosis, and cirrhosis, although the role of fibrosis is controversial. The interplay between hepatocytes, immune cells and hepatic stellate cells is a key issue. This review summarizes critical aspects of the liver tumor microenvironment paying special attention to platelets as new key players, which exert both pro- and anti-tumor effects, determined by specific contexts and a tight regulation of platelet signaling. Additionally, the relevance of specific signaling pathways, mainly HGF/MET, EGFR and TGF-β is discussed. HGF and TGF-β are produced by different liver cells and platelets and regulate not only tumor cell fate but also HPCs, inflammation and fibrosis, these being key players in these processes. The role of C3G/RAPGEF1, required for the proper function of HGF/MET signaling in HCC and HPCs, is highlighted, due to its ability to promote HCC growth and, regulate HPC fate and platelet-mediated actions on liver cancer.